Insider Selling: Jimenez Juan Jose Roman Sells 22,000 Shares of Evotec AG Stock (EVTC)
Evotec AG (NASDAQ:EVTC) CFO Jimenez Juan Jose Roman unloaded 22,000 shares of the stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $24.80, for a total transaction of $545,600.00. Following the completion of the transaction, the chief financial officer now directly owns 222,053 shares of the company’s stock, valued at approximately $5,506,914. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Evotec AG (NASDAQ:EVTC) traded down 1.57% on Thursday, hitting $24.43. The stock had a trading volume of 171,734 shares. Evotec AG has a 52 week low of $20.64 and a 52 week high of $26.33. The stock has a 50-day moving average of $23.82 and a 200-day moving average of $24.16. The company’s market cap is $1.915 billion.
Evotec AG (NASDAQ:EVTC) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.40 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.39 by $0.01. The company had revenue of $87.20 million for the quarter, compared to the consensus estimate of $91.26 million. The company’s revenue for the quarter was down .1% on a year-over-year basis. Analysts expect that Evotec AG will post $1.68 EPS for the current fiscal year.
Evotec AG is a Germany-based parent company of the Evotec group, which is engaged in drug discovery and development company focused on providing integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.